Teva Pharmaceutical Industries (TEVA) Reports Q1 Earnings: What Key Metrics Have to Say

Teva Pharmaceutical Industries Ltd. (TEVA) reported $3.89 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.9%. EPS of$ 0.52 for the same period compares to $0.48 a year ago.The reported revenue represents a surprise of -1.92% over the Zacks Consensus Estimate of$ 3.97 billion. With the consensus EPS estimate being $0.47, the EPS surprise was +10.64%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street exp ...